GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SHL Telemedicine Ltd (XSWX:SHLTN) » Definitions » EV-to-EBIT

SHL Telemedicine (XSWX:SHLTN) EV-to-EBIT : -16.60 (As of May. 16, 2024)


View and export this data going back to 2000. Start your Free Trial

What is SHL Telemedicine EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, SHL Telemedicine's Enterprise Value is CHF66.98 Mil. SHL Telemedicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-4.04 Mil. Therefore, SHL Telemedicine's EV-to-EBIT for today is -16.60.

The historical rank and industry rank for SHL Telemedicine's EV-to-EBIT or its related term are showing as below:

XSWX:SHLTN' s EV-to-EBIT Range Over the Past 10 Years
Min: -25.5   Med: 13.36   Max: 496.58
Current: -16.6

During the past 13 years, the highest EV-to-EBIT of SHL Telemedicine was 496.58. The lowest was -25.50. And the median was 13.36.

XSWX:SHLTN's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.24 vs XSWX:SHLTN: -16.60

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. SHL Telemedicine's Enterprise Value for the quarter that ended in Dec. 2023 was CHF110.93 Mil. SHL Telemedicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-4.04 Mil. SHL Telemedicine's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -3.64%.


SHL Telemedicine EV-to-EBIT Historical Data

The historical data trend for SHL Telemedicine's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SHL Telemedicine EV-to-EBIT Chart

SHL Telemedicine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.69 300.53 -23.56 104.42 -27.48

SHL Telemedicine Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.56 - 104.42 - -27.48

Competitive Comparison of SHL Telemedicine's EV-to-EBIT

For the Health Information Services subindustry, SHL Telemedicine's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SHL Telemedicine's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's EV-to-EBIT falls into.



SHL Telemedicine EV-to-EBIT Calculation

SHL Telemedicine's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=66.982/-4.036
=-16.60

SHL Telemedicine's current Enterprise Value is CHF66.98 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-4.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SHL Telemedicine  (XSWX:SHLTN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

SHL Telemedicine's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-4.036/110.93023
=-3.64 %

SHL Telemedicine's Enterprise Value for the quarter that ended in Dec. 2023 was CHF110.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SHL Telemedicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-4.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SHL Telemedicine EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of SHL Telemedicine's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


SHL Telemedicine (XSWX:SHLTN) Business Description

Traded in Other Exchanges
Address
90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world.

SHL Telemedicine (XSWX:SHLTN) Headlines

No Headlines